We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.88% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Technology | 11.2% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Avery Dennison
AVY
$12.3B
| $8.58M | 0.04% |
+40,799
| New | +$8.57M |
|
552
MPLX
MPLX
$59.5B
| $8.57M | 0.04% |
289,579
+254,446
| +724% | +$7.2M |
|
553
Huntington Bancshares
HBAN
$35.1B
| $8.56M | 0.04% |
+599,671
| New | +$9.18M |
|
554
Broadcom
AVGO
$1.82T
| $8.55M | 0.04% |
179,250
-88,890
| -33% | -$4.12M |
|
555
Gilead Sciences
GILD
$161B
| $8.55M | 0.04% |
124,096
+75,637
| +156% | +$5.05M |
|
556
Antero Resources
AR
$10.9B
| $8.54M | 0.04% |
+568,094
| New | +$6.67M |
|
557
Lennar Class A
LEN
$20.4B
| $8.48M | 0.04% |
88,144
+22,477
| +34% | +$2.17M |
|
558
Turning Point Brands
TPB
$1.47B
| $8.45M | 0.04% |
184,701
-112,997
| -38% | -$5.23M |
|
559
KeyCorp
KEY
$24.3B
| $8.45M | 0.04% |
408,997
+34,030
| +9% | +$739K |
|
560
The RealReal
REAL
$1.34B
| $8.43M | 0.04% |
426,661
+162,320
| +61% | +$3.32M |
|
|
PMVC
561
DELISTED
PMV Consumer Acquisition Corp.
PMVC
| $8.43M | 0.04% |
864,700
-18,025
| -2% | -$176K |
|
|
AUS
562
DELISTED
Austerlitz Acquisition Corporation I
AUS
| $8.43M | 0.04% |
+849,772
| New | +$8.43M |
|
563
Freshpet
FRPT
$2.83B
| $8.37M | 0.04% |
51,383
+26,097
| +103% | +$4.45M |
|
|
SNRH
564
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
| $8.31M | 0.04% |
854,336
+102,197
| +14% | +$1M |
|
565
Yext
YEXT
$501M
| $8.3M | 0.04% |
+580,817
| New | +$8.08M |
|
|
BOAS
566
DELISTED
BOA Acquisition Corp.
BOAS
| $8.29M | 0.04% |
+857,493
| New | +$8.33M |
|
|
HUGS
567
DELISTED
USHG Acquisition Corp.
HUGS
| $8.29M | 0.04% |
+854,601
| New | +$8.38M |
|
568
Frontline
FRO
$8.75B
| $8.27M | 0.04% |
917,110
+638,946
| +230% | +$5.14M |
|
|
FOE
569
DELISTED
Ferro Corporation
FOE
| $8.26M | 0.04% |
382,904
+144,396
| +61% | +$2.84M |
|
570
JD.com
JD
$40.8B
| $8.25M | 0.04% |
103,363
-138,157
| -57% | -$10.4M |
|
571
GFL Environmental
GFL
$14.3B
| $8.22M | 0.04% |
+257,205
| New | +$8.42M |
|
572
BlackBerry
BB
$5.01B
| $8.19M | 0.04% |
669,952
+540,752
| +419% | +$5.66M |
|
573
Fortis
FTS
$30B
| $8.19M | 0.04% |
184,723
+159,123
| +622% | +$7.17M |
|
|
EQHA
574
DELISTED
EQ Health Acquisition Corp.
EQHA
| $8.18M | 0.04% |
+846,230
| New | +$8.26M |
|
575
Paycom
PAYC
$6.78B
| $8.17M | 0.04% |
22,478
+755
| +3% | +$268K |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.